| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/10/2001 | WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032646A2 Sulfonamide derivatives |
| 05/10/2001 | WO2001032633A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | WO2001032625A1 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001032577A1 Pigmented vitreous material its precursor glass items coated therewith and method of its preparation |
| 05/10/2001 | WO2001032174A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 05/10/2001 | DE19953830A1 Novel sulfur-containing compounds such as 5-propyl-thiophene-2-carboxylic acid-(4-(5-undecyl-pyrimidine-2-yl)-phenyl)-thioester are useful as dopants for improving the properties of liquid crystal mixtures |
| 05/10/2001 | DE19953804A1 Novel tetrahydrothiophene compounds such as 5-propyl-tetrahydrothiophene-2-carboxylic acid-(4-(5-undecyl-pyrimidine-2-yl)-phenyl)-ester are useful as dopants for improving the properties of liquid crystal mixtures |
| 05/10/2001 | CA2389807A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389377A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 05/10/2001 | CA2389259A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists |
| 05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/09/2001 | EP1097932A1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same |
| 05/09/2001 | CN1294584A Substituted aminoalkylidenamino triazines as herbicides |
| 05/09/2001 | CN1294579A Sulfonamide-contg. indole compounds |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228881 Aromatic heterocyclic compounds and their use as anti-inflammatory agents |
| 05/08/2001 | US6228876 Administering 1-(1,3-dioxolan-2-ylmethy)l- or 1-(1,3-dioxan-2-ylmethyl)-1h-1,2,4-triazole derivative |
| 05/08/2001 | US6228871 Angiogenesis inhibitors |
| 05/08/2001 | US6228869 Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 05/08/2001 | US6228865 Compounds useful for inhibition of farnesyl protein transferase |
| 05/08/2001 | US6228860 Substituted 1,3-oxathiolanes with antiviral properties |
| 05/08/2001 | US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction |
| 05/08/2001 | US6228810 Outstanding efficacy against broad spectrum of phytopathogenic fungi; effective control of pests from classes of insects, arachnids and nematodes |
| 05/08/2001 | US6228809 Substituted aminophenyluracils as herbicides and insecticides |
| 05/08/2001 | CA2032330C Benzyl-substituted rhodanine derivatives for treating inflammatory bowel disease |
| 05/03/2001 | WO2001030795A1 Hygromycin derivatives |
| 05/03/2001 | WO2001030777A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors |
| 05/03/2001 | WO2001030762A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
| 05/03/2001 | WO2001030330A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 05/03/2001 | WO2001030151A1 Methods of treating hair loss comprising administering indoline compound |
| 05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | CA2389191A1 Hygromycin derivatives |
| 05/03/2001 | CA2388119A1 Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors |
| 05/03/2001 | CA2387869A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
| 05/03/2001 | CA2386889A1 Methods of treating hair loss comprising administering indoline compound |
| 05/03/2001 | CA2386441A1 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 05/02/2001 | EP1095938A1 Oxetane compounds, oxetane copolymer, and process for producing oxetane compounds |
| 05/02/2001 | EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/02/2001 | EP1095039A2 New pharmaceutically active compounds |
| 05/02/2001 | EP1095031A1 Antiviral macrocyclic compounds |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293192A New benzothiophene, benzofuran and indole compounds, preparation method therefor and medicine composition containing same |
| 05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
| 05/01/2001 | US6225478 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 05/01/2001 | US6225467 Uniform luminescence, electroluminescent efficiency, durability, low driving voltage; for use in flat-panel emissive display technologies, including television screens, computer screens |
| 05/01/2001 | US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225312 Piperazine and piperidine compounds |
| 05/01/2001 | US6225309 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 04/26/2001 | WO2001029245A2 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS |
| 04/26/2001 | WO2001029033A2 Thiono-thiochroman and -dihydrobenzothiophene compounds as herbicidal agents |
| 04/26/2001 | WO2001029030A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029021A1 Neuraminidase inhibitors |
| 04/26/2001 | WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029008A1 Pyrazole derivatives which modulate human serotonin receptors |
| 04/26/2001 | WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028537A2 Bissulfonamide derivatives as enzyme inhibitors |
| 04/26/2001 | WO2000071519A3 Immunopotentiator agents |
| 04/26/2001 | WO2000059902A3 Aryl sulfonyls as factor xa inhibitors |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000511 Treatment of skin disorders, inflammation, nerve system disorders, cancer |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/26/2001 | CA2388859A1 Inhibitors of neuraminidases |
| 04/26/2001 | CA2387972A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 04/26/2001 | CA2387593A1 Enzyme inhibitors |
| 04/26/2001 | CA2387031A1 Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
| 04/26/2001 | CA2386487A1 Enzymatic process for the resolution of enantiomeric mixtures of .beta.-lactams |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | CN1064965C Novel sulfonamides compound and its use as medicine |
| 04/25/2001 | CN1064959C N-substituted azabicycloheptane derivatives and preparing process and use thereof |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6221869 N-aminoalkyldibenzothiophenecarboxamides new dopamine receptor subtype specific ligands |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | US6221637 Immunomodulators for treating graft rejection, or nephritis; inhibits signal transduction by t-cells; methyl 2-(carboxymethylsulfinyl)-5,7-dichloro-3,8-dihydroxy-6-methyl-9-oxo-9h -xanthene-1-carboxylate, for example |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001027108A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027103A1 Fab i inhibitors |
| 04/19/2001 | WO2001027091A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |